2.
局限期小细胞肺癌患者治疗相关毒性(n=26) [n (%)]
Treatment-related toxicities of patients with LS-SCLC (n=26) [n (%)]
| Grade 0 | Grade 1 | Grade 2 | Grade 3 | Grade 4 | Grade 5 | |
| Hematological toxicity | ||||||
| Leukemia | 0 (0) | 0 (0) | 10 (38.5) | 15 (57.7) | 1 (3.8) | - |
| Neutropenia | 1 (3.8) | 1 (3.8) | 7 (26.9) | 13 (50.0) | 4 (15.4) | - |
| Anemia | 6 (23.1) | 14 (53.8) | 5 (19.2) | 1 (3.8) | 0 (0) | - |
| Thrombocytopenia | 9 (34.6) | 6 (23.1) | 8 (30.8) | 3 (11.5) | 0 (0) | - |
| Non-hematological toxicity | ||||||
| Fatigue | 2 (7.7) | 17 (65.4) | 6 (23.1) | 1 (3.8) | 0 (0) | 0 (0) |
| Nausea | 16 (61.5) | 8 (30.8) | 2 (7.7) | 0 (0) | 0 (0) | 0 (0) |
| Anorexia | 21 (80.8) | 3 (11.5) | 2 (7.7) | 0 (0) | 0 (0) | 0 (0) |
| Dysphagia | 15 (57.7) | 2 (7.7) | 8 (30.8) | 1 (3.8) | 0 (0) | 0 (0) |
| Esophagitis | 12 (46.2) | 1 (3.8) | 12 (46.2) | 1 (3.8) | 0 (0) | 0 (0) |
| Pneumonitis | 21 (80.0) | 2 (7.7) | 3 (11.5) | 0 (0) | 0 (0) | 0 (0) |
| Hepatic injury | 20 (76.9) | 4 (15.4) | 1 (3.8) | 1 (3.8) | 0 (0) | 0 (0) |
| hyperbilirubinemia | 22 (84.6) | 3 (11.5) | 1 (3.8) | 0 (0) | 0 (0) | 0 (0) |